/SNYR
SNYR Stock - Synergy CHC Corp.
Healthcare|Medical - DistributionNASDAQ
$1.83+1.67%
+$0.03 (+1.67%) • Dec 19
63
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.4
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.84
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+446.4%upside
Target: $10.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SNYR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.81 – $1.85
TARGET (TP)$10.00
STOP LOSS$1.68
RISK/REWARD1:54.5
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.91
52W High$5.01
52W Low$1.30
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $34.83M | $42.78M | $38.41M | $40.23M | $29.36M |
| Gross Profit | $23.64M | $32.08M | $12.96M | $25.55M | $20.22M |
| Gross Margin | 67.9% | 75.0% | 33.7% | 63.5% | 68.9% |
| Operating Income | $5.80M | $10.81M | $-24,966,263 | $3.09M | $-7,956,110 |
| Net Income | $2.12M | $6.34M | $-32,631,287 | $1.41M | $-9,207,447 |
| Net Margin | 6.1% | 14.8% | -85.0% | 3.5% | -31.4% |
| EPS | $0.28 | $0.86 | $-0.36 | $0.02 | $-0.10 |
Company Overview
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; lifestyle products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name; anti-aging skincare products, such as serums and creams for exfoliating, skin repair, and rehydration, as well as hand soaps and hand sanitizers under the Hand MD brand name. The company sells its products through retailers and television advertising campaigns, as well as skincare products through online. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. Synergy CHC Corp. was incorporated in 2010 and is based in Westbrook, Maine.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
1
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
1 Bullish0 Neutral/Bearish
Price Targets
$10
Average Target
↑ 446.4% Upside
Now
$10
Low
$10
Average
$10
High
Based on 1 analyst
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| January 21st 2025 | ROTH MKM | Initiation | Buy | $10 |
Earnings History & Surprises
SNYRBeat Rate
40%
Last 5 quarters
Avg Surprise
+13.1%
EPS vs Estimate
Beats / Misses
2/1
2 met exactly
Latest EPS
$0.01
Q4 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q4 24
0.0%
$0.10vs$0.10
Q1 25
-90.0%
$0.01vs$0.10
Q2 25
+42.9%
$0.10vs$0.07
Q3 25
+112.5%
$0.17vs$0.08
Q4 25
0.0%
$0.01vs$0.01
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 30, 2026 | $0.01 | — | — | — |
Q4 2025 | Nov 13, 2025 | $0.01 | $0.01 | 0.0% | = MET |
Q3 2025 | Aug 14, 2025 | $0.08 | $0.17 | +112.5% | ✓ BEAT |
Q2 2025 | May 15, 2025 | $0.07 | $0.10 | +42.9% | ✓ BEAT |
Q1 2025 | Mar 31, 2025 | $0.10 | $0.01 | -90.0% | ✗ MISS |
Q4 2024 | Dec 6, 2024 | $0.10 | $0.10 | 0.0% | = MET |
Q2 2024 | Jun 30, 2024 | — | $0.91 | — | — |
Q1 2024 | Mar 31, 2024 | — | $0.08 | — | — |
Q4 2023 | Dec 31, 2023 | — | $0.03 | — | — |
Q3 2023 | Sep 29, 2023 | — | $0.01 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.02 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.01 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.02 | — | — |
Q3 2020 | Sep 30, 2020 | — | $0.02 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.01 | — | — |
Q1 2020 | Mar 31, 2020 | — | $0.00 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.12 | — | — |
Q4 2019 | Nov 14, 2019 | — | $0.00 | — | — |
Latest News
Synergy CHC Launches $5.69M At-The-Market Offering Of Common Stock
📉 NegativeBenzinga•Dec 9, 2025, 09:39 PM
Synergy CHC May Offer Securities Up To $100M
➖ NeutralBenzinga•Nov 26, 2025, 09:43 PM
Roth Capital Maintains Buy on Synergy CHC, Lowers Price Target to $7
📈 PositiveBenzinga•Nov 14, 2025, 05:41 PM
Synergy CHC Q3 EPS $0.01, Inline, Sales $8.010M Miss $10.900M Estimate
📉 NegativeBenzinga•Nov 13, 2025, 01:03 PM
Synergy Enters Distribution Partnership With Atlantic Importing Company To Expand Retail Availability Of Its FOCUSfactor Focus + Energy Beverages And Brain-Health Shots Across Massachusetts, Connecticut, And Rhode Island
📈 PositiveBenzinga•Oct 20, 2025, 12:03 PM
SNYR stock has given up its prior gain. Synergy CHC shares were trading higher after the company announced a strategic distribution partnership with AlaBev , to expand retail availability of its flagship FOCUSfactor Focus + Energy functional beverage line and brain-health energy shots.
➖ NeutralBenzinga•Sep 17, 2025, 01:41 PM
Synergy CHC shares are trading higher after the company announced a strategic distribution partnership with AlaBev , to expand retail availability of its flagship FOCUSfactor Focus + Energy functional beverage line and brain-health energy shots.
📈 PositiveBenzinga•Sep 17, 2025, 01:11 PM
Synergy CHC Partners With AlaBev To Expand Retail Availability Of FOCUSfactor Focus + Energy Functional Beverage Line And Brain-Health Energy Shots
📈 PositiveBenzinga•Sep 17, 2025, 01:09 PM
Synergy CHC Launches $4.4M Stock Offering Of 1.75M Shares At $2.50 Each For Working Capital And Corporate Use
➖ NeutralBenzinga•Aug 26, 2025, 08:32 PM
Synergy CHC shares are trading lower after the company announced a $4.375 million public offering.
📉 NegativeBenzinga•Aug 26, 2025, 12:46 PM
Reported Earlier, Synergy CHC Corp Announces Pricing Of $4.375M Public Offering Of 1.75M Common Shares At $2.50 Per Share
➖ NeutralBenzinga•Aug 26, 2025, 05:50 AM
Synergy Chc EPS Jumps 86 Percent in Q2
📈 PositiveThe Motley Fool•Aug 14, 2025, 12:20 PM
Frequently Asked Questions about SNYR
What is SNYR's current stock price?
Synergy CHC Corp. (SNYR) is currently trading at $1.83 per share. The stock has moved +1.67% today.
What is the analyst price target for SNYR?
The average analyst price target for SNYR is $10.00, based on 1 analyst.
What sector is Synergy CHC Corp. in?
Synergy CHC Corp. operates in the Healthcare sector, specifically within the Medical - Distribution industry. The company is traded on the NASDAQ exchange.
What is SNYR's market cap?
Synergy CHC Corp. has a market capitalization of $0.02 billion, making it a small-cap company.
Does SNYR pay dividends?
No, Synergy CHC Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADGM
Adagio Medical Holdings, Inc.
$1.03
Mkt Cap: $0.0B
ALLR
Allarity Therapeutics, Inc.
$1.03
Mkt Cap: $0.0B
CING
Cingulate Inc.
$3.97
Mkt Cap: $0.0B
CLSD
Clearside Biomedical, Inc.
$1.00
Mkt Cap: $0.0B
COCH
Envoy Medical, Inc.
$0.73
Mkt Cap: $0.0B
LNAI
Lunai Bioworks Inc.
$1.05
Mkt Cap: $0.0B
NXL
Nexalin Technology, Inc.
$0.83
Mkt Cap: $0.0B
PCSA
Processa Pharmaceuticals, Inc.
$3.78
Mkt Cap: $0.0B
PRPH
ProPhase Labs, Inc.
$0.09
Mkt Cap: $0.0B
RLYB
Rallybio Corporation
$0.79
Mkt Cap: $0.0B
Explore stocks similar to SNYR for comparison